Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Genvoya |
| Active Ingredients: | Cobicistat 150mg Elvitegravir 150mg Emtricitabine 200mg Tenofovir alafenamide 10mg |
| Dosage Form: | Tablet |
| New Zealand Sponsor: | Gilead Sciences (NZ) |
| Manufacturers: | Patheon Inc, Toronto Region Operations (TRO), Mississauga, Canada Gilead Sciences Ireland UC, Carrigtohill, Ireland |
| Product: | Vivotif Oral |
| Active Ingredient: | Salmonella typhi strain TY21A Berna 2000million organisms |
| Dosage Form: | Modified release capsule |
| New Zealand Sponsor: | Seqirus (NZ) Limited |
| Manufacturer: | Emergent BioSolutions Berna GmbH, Thorishaus, Switzerland |
Dated this 28th day of February 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).